Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Charles Kreilick"'
Autor:
Augustina Ogbonnaya, Michael Eaddy, Jonathan Kish, Avin Yaldo, Adriana Valderrama, Katarzyna Shields, Charles Kreilick, Krishna Tangirala, L. Wen
Publikováno v:
Clinical therapeutics. 38(8)
The development of skeletal-related events (SREs) (pathologic fracture, need for surgery and/or radiation to bone, spinal cord compression, and hypercalcemia of malignancy) in metastatic prostate cancer (MPC) is associated with worsened pain and comp
Publikováno v:
Advances in Therapy. 27:600-612
This retrospective cohort study compared the direct medical costs of successful versus unsuccessful catheter ablation in Medicare-aged patients with atrial fibrillation (AF), using medical claims data.AF patients withor = 12 months of continuous medi
Publikováno v:
Advances in Therapy. 27:623-633
Few studies have investigated current practices in the USA relating to warfarin use and monitoring, or the effects of warfarin discontinuation on risk of venous thromboembolism (VTE) and bleeding complications. This study investigated the effect of w
Publikováno v:
Advances in Therapy. 26:784-794
The Medicare Part D prescription plan has a coverage gap from $2250 to $5100 per year (2006 thresholds) in which patients pay full drug costs (the "donut hole"). We examined prescription costs in patients agedor=65 years with atrial fibrillation (AF)
Autor:
Judith J. Stephenson, Stephen J. Boccuzzi, Jennifer Kim, Ole Hauch, Charles Kreilick, John Martin, Joaquim Fernandes, Jane F. Beaulieu
Publikováno v:
Current medical research and opinion. 25(12)
To determine the direct healthcare costs associated with the onset of chronic nonvalvular atrial fibrillation (CNVAF), warfarin utilization and the occurrence of cerebrovascular events in a commercially-insured population.This retrospective, observat
Publikováno v:
Advances in therapy. 26(9)
Atrial fibrillation (AF) has been shown to be associated with high healthcare costs; however, limited data are available from large-scale studies quantifying the overall cost burden of AF in the USA. We therefore aimed to provide an up to date estima
Autor:
Kellie Morland, Erin Zagadailov, Brian S. Seal, Michael Eaddy, Carl V. Asche, Kenneth M. Shermock, Charles Kreilick, Jane Chang, Jianying Yao, Jen Cameron
Publikováno v:
Journal of Clinical Oncology. 33:e15510-e15510
e15510 Background: This study evaluated patterns of care among patients diagnosed and treated for bladder cancer with and without metastases. Methods: Retrospective data from 2 large integrated cla...
Autor:
Avin Yaldo, Adriana Valderrama, Brian S. Seal, Michael Eaddy, Jonathan Kish, Charles Kreilick, L. Wen, Augustina Ogbonnaya
Publikováno v:
Journal of Clinical Oncology. 33:278-278
278 Background: Bone metastases (mets) occur in ≥90% of men with castrate-resistant prostate cancer (PC), causing significant pain and resource use. Opioids are frequently used in managing pain throughout the course of care, but few studies have qu
Publikováno v:
Journal of Clinical Oncology. 31:e14658-e14658
e14658 Background: Patterns and cost of care are thought to vary substantially as patients with colorectal cancer (CRC) progress from first to third line therapy and in the presence of metastatic disease. Our aim was to compare patterns and cost of c
Autor:
Sally Haislip, Satish Valluri, James Gilmore, Stephen Szabo, Susan Boklage, Charles Kreilick, Kenneth M. Shermock, Carl V. Asche, Sean D. Sullivan, Kai Sun, Scott D. Ramsey, Brian S. Seal, Syam Sarma
Publikováno v:
Journal of Clinical Oncology. 30:e15183-e15183
e15183 Background: Clinical studies showed that chemotherapy (CT) yields survival benefits for Metastatic Castrate resistant prostate cancer (CRPC) patients. This study investigated the relationship between patients with 2nd CT and OS using a real-wo